Abbott Laboratories SEC filings ABT

Abbott Laboratories has 1,001 filings in SEC EDGAR's recent list, going back to Jul 12, 2018. Its latest annual report, Form ARS, was filed on Mar 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (other events). The company's fiscal year ends on December 31.

Form Description Filed Period
S-8 Employee stock plan registration Apr 24, 2026 —
S-8 Employee stock plan registration Mar 23, 2026 —
424B5 Prospectus supplement Feb 25, 2026 —
FWP Free writing prospectus Feb 24, 2026 —
424B3 Prospectus Feb 23, 2026 —
S-3ASR Automatic shelf registration Feb 23, 2026 —
S-3ASR Automatic shelf registration May 3, 2023 —
S-8 Employee stock plan registration Dec 14, 2020 —
S-8 Employee stock plan registration Dec 14, 2020 —
424B5 Prospectus supplement Jun 23, 2020 —
FWP Free writing prospectus Jun 22, 2020 —
424B5 Prospectus supplement Jun 22, 2020 —
S-3ASR Automatic shelf registration Jun 22, 2020 —
S-8 Employee stock plan registration Oct 12, 2018 —
S-8 Employee stock plan registration Oct 12, 2018 —
S-8 Employee stock plan registration Oct 12, 2018 —

Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ABT (NYSE)
Fiscal year ends
December 31
Incorporated in
IL
Headquarters
Abbott Park, IL
SEC filer status
Large accelerated filer
SEC CIK
1800

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.